In addition to miRNAs, treating MI rats with growth differentiation factor 15 (GDF15)-enriched rEVs also markedly reduces infarct size and improves LVEF compared with PBS or naive EV treated controls, probably through mitigating post-MI inflammation, cardiac apoptosis and the promotion of angiogenesis172. This evidence concerns the gene GDF15 and myocardial infarction.